Phase I and pharmacologic study of the arotinoid Ro 40-8757 in combination with cisplatin and etoposide in patients with non-small cell lung cancer

L. van Zuylen, J.H.M. Schellens

Research output: Contribution to journalArticleProfessional

Original languageEnglish
Pages (from-to)361-368
Number of pages7
JournalAnti-Cancer Drugs
Volume10
Publication statusPublished - 1999

Cite this